Mindfulness-Based Intervention With a Supplement for Stress-Related Problems in College Students Across Multiple Sites (4SITE) (4SITE)
Testing a Mindfulness-Based Intervention With a Multi-Modal Adaptive Supplement for Stress-Related Problems in College Students
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Rachel Lucas-Thompson, PhD
- Phone Number: 970-491-5718
- Email: lucas-thompson.rachel.graham@colostate.edu
Study Locations
-
-
Colorado
-
Denver, Colorado, United States, 80204
- University of Colorado Denver
-
Fort Collins, Colorado, United States, 80523
- Colorado State University
-
-
Minnesota
-
Saint Paul, Minnesota, United States, 55108
- University of Minnesota
-
Saint Paul, Minnesota, United States, 55105
- Macalester College
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- aged 18-25 years
- enrolled in a college or university
- experiencing elevated stress
- plan to be available in-person in the semester following the study
- own a smart phone.
Exclusion Criteria:
- have several depressive symptoms
- have suicidal ideation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Learning to BREATHE (L2B)
|
L2B is a group MBI designed for adolescents (Broderick & Metz, 2009) and teaches three families of practices: focused attention (e.g., breath awareness), open awareness (i.e., awareness of sensations, thoughts, and feelings as they occur), and compassion.
Each letter in BREATHE corresponds to a theme: Body, Reflections, Emotions, Attention, Tenderness, and Habits, building to the overall goal of Empowerment.
Each session involves guided discussions, activities, and mindfulness practices.
Other Names:
|
|
Experimental: Learning to BREATHE Plus (L2B PLUS)
|
The in-person, group program portion of L2B PLUS and L2B are identical.
But, L2B PLUS (Lucas-Thompson et al., 2020) builds on the standard L2B program with 3 additional supplements: 1) Extensive on-demand library designed by the team to be integrated with the group program and specifically to allow participants to independently practice skills that have already been introduced in the group program.
2) Intervention messages sent across the day.
The team developed intervention messages to be sent 5 times a day to participants (Lucas-Thompson et al., 2020).
Each week, participants receive intervention content tailored to what they have just learned in the group program.
3) JIT support.
When participants indicate high stress via EMAs completed during the intervention period, tailored intervention content is delivered "just-in-time" during a moment of high need.
These JIT messages were developed specifically to support applying or using mindfulness during periods of high stress.
Other Names:
|
|
Active Comparator: HealthEd
|
Hey-Durham is a health education program that the team has extensive experience implementing (Lucas-Thompson et al., 2019; Shomaker, Berman, et al., 2019; Shomaker et al., 2016; Tanofsky-Kraff et al., 2014) and covers topics such as domestic violence, substance use, depression/signs of suicide, and conflict resolution.
Mental health components focus only on prevalence and identification.
There is no content overlap with L2B, but it is matched to L2B in format, time, frequency, in-person contact, and facilitator expertise.
Inclusion of HealthEd in a future efficacy trial will allow us to test the extent to which the active ingredients of MBI (i.e,. a top-down and bottom-up focus on emotion and stress regulation(Zelazo & Carlson, 2012)), with and without the between-session support L2B, improve mental health and stress responding, relative to an active control matched for critical characteristics but that does not include these active ingredients.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Program-specific intervention knowledge evaluations
Time Frame: 2 months before baseline
|
Post-training L2B, L2B PLUS, and HealthEd knowledge assessments (0-25) will be completed by facilitators with higher scores indicating higher intervention knowledge
|
2 months before baseline
|
|
Number of eligible participants recruited with elevated stress as assessed by the Perceived Stress Scale
Time Frame: Within a 12-month period
|
Study goal of 120 participants total across 4 sites who have elevated stress (>14) on the Perceived Stress Scale (0-40) where higher scores indicate higher stress
|
Within a 12-month period
|
|
Program-specific facilitator adherence ratings of mock intervention group sessions
Time Frame: 2 months before baseline
|
Facilitator adherence to each intervention manual (0-100) for L2B, L2B PLUS, and HealthEd, during mock sessions after intervention facilitation training where higher scores mean higher adherence
|
2 months before baseline
|
|
Program-specific facilitator competence ratings of mock intervention group sessions
Time Frame: 2 months before baseline
|
Facilitator competence of each intervention manual (0-100) for L2B, L2B PLUS, and HealthEd, during mock sessions after intervention facilitation training where higher scores mean higher competence
|
2 months before baseline
|
|
Percentage of eligible students who enroll
Time Frame: Within a 12-month period
|
Within a 12-month period
|
|
|
Percentage of enrolled participants who attend 5/6 intervention sessions
Time Frame: During 6-week interventions
|
During 6-week interventions
|
|
|
Acceptability ratings of intervention by participants
Time Frame: Within one-month of intervention end
|
Acceptability ratings (1-5) with higher scores meaning higher acceptability
|
Within one-month of intervention end
|
|
Qualitative assessment of acceptability of interventions
Time Frame: Within one-month of intervention end
|
Focus within group programs will qualitatively assess the acceptability of interventions
|
Within one-month of intervention end
|
|
Percent of participants retained at post-test
Time Frame: Post intervention, 6 weeks after baseline
|
Post intervention, 6 weeks after baseline
|
|
|
Percent retention at six-month follow-up
Time Frame: 32 weeks after baseline
|
32 weeks after baseline
|
|
|
Adherence to standardized data collection protocol measured via standardized checklists
Time Frame: At baseline, 6 weeks after, and 32 weeks after
|
Percentage of data collection protocol adhered to by assessors (0-100) with higher scores indicating better adherence
|
At baseline, 6 weeks after, and 32 weeks after
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depressive Symptoms
Time Frame: At baseline, 6 weeks after, and 32 weeks after
|
Participant depressive symptoms will be assessed using the Center for Epidemiological Studies Depression Scale (Radloff, 1977).
The Center for Epidemiological Studies Depression Scale has 20 questions rated on a 1-4 Likert scale where higher scores indicate higher depressive symptoms.
|
At baseline, 6 weeks after, and 32 weeks after
|
|
Clinical Depression
Time Frame: At baseline, 6 weeks after, and 32 weeks after
|
Participant levels of clinical depression will be assessed using the Beck Depression Inventory (Beck et al., 1961).
The Beck Depression Inventory has 21 questions rated on a 0-3 Likert scale where higher scores indicate higher depressive symptoms.
|
At baseline, 6 weeks after, and 32 weeks after
|
|
Anxiety
Time Frame: At baseline, 6 weeks after, and 32 weeks after
|
Participant anxiety will be assessed using the State-Trait Anxiety Inventory (Beiling et al., 1998).
It has 20 questions rated on a 1-4 Likert scale where higher scores indicate higher anxiety.
|
At baseline, 6 weeks after, and 32 weeks after
|
|
Perceived Stress
Time Frame: At baseline, 6 weeks after, and 32 weeks after
|
Participant perceived stress will be assessed using the Perceived Stress Scale (Cohen et al., 1983).
It has 14 questions rated on a 0-4 Likert scale where higher scores indicate higher perceived stress.
|
At baseline, 6 weeks after, and 32 weeks after
|
|
Social Support
Time Frame: At baseline, 6 weeks after, and 32 weeks after
|
Participant social support will be assessed using the Multidimensional Scale of Percevied Social Support (Zimet et al., 1988).
It has 12 questions rated on a 1-7 Likert scale where higher scores indicate higher social support.
|
At baseline, 6 weeks after, and 32 weeks after
|
|
Meaning in Life
Time Frame: At baseline, 6 weeks after, and 32 weeks after
|
Participant meaning in life will be assessed using the Meaning in Life Questionaire (Steger et al., 2006).
It has 10 questions rated on a 1-7 Likert scale where higher scores indicate higher meaning in life.
|
At baseline, 6 weeks after, and 32 weeks after
|
|
Mindful Attention
Time Frame: At baseline, 6 weeks after, and 32 weeks after
|
Participant mindful attention will be assessed using the Mindful Attention and Awareness Scale (Brown et al., 2011).
It has 14 questions rated on a 1-6 Likert scale where higher scores indicate higher mindful attention.
|
At baseline, 6 weeks after, and 32 weeks after
|
|
Self Compassion
Time Frame: At baseline, 6 weeks after, and 32 weeks after
|
Participant self compassion will be assessed using the Self Compassion Scale Short Form Attention (Raes et al., 2011).
It has 12 questions rated on a 1-5 Likert scale where higher scores indicate higher self compassion.
|
At baseline, 6 weeks after, and 32 weeks after
|
|
Application of Mindfulness
Time Frame: At baseline, 6 weeks after, and 32 weeks after
|
Participant application of mindfulness will be assessed using the Applied Mindfulness Process Scale (Roemer & Medvedev, 2022).
It has 15 questions rated on a 1-5 Likert scale where higher scores indicate higher mindfulness application.
|
At baseline, 6 weeks after, and 32 weeks after
|
|
Previous Experience with Mindfulness
Time Frame: At baseline, 6 weeks after, and 32 weeks after
|
Participant previous experience with mindfulness will be assessed using the mindfulness experience and knowledge questionnaire (Qian Lau & Olivia, 2023).
The mindfulness experience and knowledge questionnaire has 1 question rated on a 1-5 scale where higher scores indicate more previous mindfulness experiences.
|
At baseline, 6 weeks after, and 32 weeks after
|
|
Previous Experience with Meditation
Time Frame: At baseline, 6 weeks after, and 32 weeks after
|
Participant previous experience with mindfulness will be assessed using a meditation questionnaire (Russell et al., 2018).
The meditation questionnaire has 3 questions rated on a 1-3 Likert scale where higher scores mean more meditation knowledge.
|
At baseline, 6 weeks after, and 32 weeks after
|
|
Cortisol stress reactivity
Time Frame: 3 visits; baseline, after 6-week intervention, and at 6-month followup
|
Cortisol reactivity to a stressor will be assessed via saliva samples collected before stressor as a test, before stressor as a baseline, immediately after stressor, and 10 minutes and 20minutes after stressor.
Area under the curve will be calculated.
|
3 visits; baseline, after 6-week intervention, and at 6-month followup
|
|
Blood pressure reactivity
Time Frame: 3 visits; baseline, after 6-week intervention, and at 6-month followup
|
To assess blood pressure reactivity to a stressor, participant blood pressure will be measured at three minutes intervals across baseline and during the stressor.
Change from baseline to stressor will be calculated.
|
3 visits; baseline, after 6-week intervention, and at 6-month followup
|
|
Heart rate reactivity
Time Frame: 3 visits; baseline, after 6-week intervention, and at 6-month followup
|
To assess cardiovascular reactivity to a stressor, participant heart rate will be measured at three minutes intervals across baseline and during the stressor.
Change from baseline to stressor will be calculated.
|
3 visits; baseline, after 6-week intervention, and at 6-month followup
|
|
Daily mindful attention
Time Frame: During the 6-week group program
|
On a 5 question scale, with answer choices ranging from 1-6 (Brown & West, 2003), participants will report on their mindfulness each day during the group program.
Higher scores indicate greater mindlessness.
|
During the 6-week group program
|
|
Daily self-compassion
Time Frame: During the 6-week group program
|
Participants will report their self-compassion each day during the group program using two questions (answer choices: 1 not at all to 10 extremely), with high scores indicating greater self-compassion.
|
During the 6-week group program
|
|
Daily home practice of intervention material
Time Frame: During the 6-week group program
|
Each day during the group program, participants will be asked to describe the extent to which the formally (1 question) and informally (1 question) engaged with what they learned in their group program (Bijkerk et al., 2023).
Higher scores indicate greater engagement.
|
During the 6-week group program
|
|
Daily negative events
Time Frame: During the 6-week group program
|
Participants will list up to 5 negative events that occurred each day and, for each, rate their severity (from 0=not at all severe to 5=extremely severe) (Hankin et al., 2005).
|
During the 6-week group program
|
|
Daily psychological distress
Time Frame: During the 6-week group program
|
Each day, participants will be asked to report their psychological distress using the short-form (4 item) of the perceived stress scale (Cohen et al., 1983).
Answer choices range from 1=never to 5=very often; higher scores indicate greater distress.
|
During the 6-week group program
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Rachel Lucas-Thompson, Dr., Colorado State University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 5036
- 1R01AT012652 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.